Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Oestrogens are key for bone growth during puberty in both boys and girls.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

A male with aromatase deficiency improved bone health with estradiol treatment.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Balding men had lower bone density, while balding women had higher hip bone density.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.